National Institutes of Health
Research to Improve Rigor, Replicability, and Reproducibility in Biomedical and Behavioral Sciences
UpcomingDecision brief
- Who can apply
- OtherGovernmentHigher EducationSmall BusinessNonprofitsNonprofits (preferred)
- Award amount
- Not specified
- Deadline
- May 25, 2027
- Geography
- National
- Application notesMedium effort
- Federal application
Next step
Apply at Grants.gov
Focus areas
About this grant
The National Institute of Neurological Disorders and Stroke (NINDS), in collaboration with other National Institutes of Health (NIH) Institutes, Centers, and Offices, intends to support research projects that directly improve or evaluate biomedical and behavioral rigor, replicability, and reproducibility. Example projects include, but are not limited to: Assessing the scientific and behavioral impact of improving rigor, replicability, and reproducibility Developing decision-making frameworks to select candidate studies for replication with the highest potential for scientific value or novel insights Measuring replicability, reproducibility, robustness, and generalizability of important research findings to accelerate scientific innovation Applications are not being solicited at this time. This notice is to allow applicants time to develop collaborations and responsive projects.
Additional details
- CFDA / ALN Number
- 93.853
- Program Title
- Extramural Research Programs in the Neurosciences and Neurological Disorders
- Funding Instrument
- Grant
- Source
- Grants.gov · View original listing
Similar grants
Bureau of Global Health Security and Diplomacy
Advancing Global Health
$500K – $250MFeb 14, 2027AmeriCorps
Fiscal Year (FY) 2027 AmeriCorps State and National Competitive Grants
Jan 13, 2027AmeriCorps
Fiscal Year (FY) 2027 AmeriCorps Seniors RSVP Competition
6 days — Oct 20, 2026Health Resources and Services Administration
Fiscal Year (FY) 2027 Service Area Competition (SAC)
$650K – $10.1M5 days — Oct 19, 2026National Institutes of Health
Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
27 days — Nov 10, 2026National Institutes of Health
HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
Feb 9, 2029